Antibodies as drugs-a Keystone Symposia report.
SARS-CoV-2
allergies
antibodies
antibody design
bispecific antibodies
therapeutic antibodies
Journal
Annals of the New York Academy of Sciences
ISSN: 1749-6632
Titre abrégé: Ann N Y Acad Sci
Pays: United States
ID NLM: 7506858
Informations de publication
Date de publication:
01 2023
01 2023
Historique:
pubmed:
17
11
2022
medline:
12
1
2023
entrez:
16
11
2022
Statut:
ppublish
Résumé
Therapeutic antibodies have broad indications across diverse disease states, such as oncology, autoimmune diseases, and infectious diseases. New research continues to identify antibodies with therapeutic potential as well as methods to improve upon endogenous antibodies and to design antibodies de novo. On April 27-30, 2022, experts in antibody research across academia and industry met for the Keystone symposium "Antibodies as Drugs" to present the state-of-the-art in antibody therapeutics, repertoires and deep learning, bispecific antibodies, and engineering.
Identifiants
pubmed: 36382536
doi: 10.1111/nyas.14915
pmc: PMC10103175
mid: NIHMS1886487
doi:
Substances chimiques
Antibodies, Bispecific
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
153-166Subventions
Organisme : NIAID NIH HHS
ID : R01 AI143865
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM008320
Pays : United States
Organisme : Wellcome Trust
ID : 208710/Z/17/Z
Pays : United Kingdom
Organisme : Howard Hughes Medical Institute
Pays : United States
Informations de copyright
© 2022 New York Academy of Sciences.
Références
Cleve Clin J Med. 2013 Nov;80(11):711-21
pubmed: 24186889
J Clin Invest. 2022 Jun 15;132(12):
pubmed: 35503254
Science. 2020 Oct 23;370(6515):
pubmed: 32972996
PLoS One. 2012;7(4):e35005
pubmed: 22506061
Elife. 2019 Jun 27;8:
pubmed: 31244472
Nat Rev Immunol. 2019 Apr;19(4):218-230
pubmed: 30679808
Science. 2022 Mar 4;375(6584):eabk2432
pubmed: 35239393
Sci Transl Med. 2015 May 13;7(287):287ra70
pubmed: 25972002
Blood. 2018 Mar 15;131(11):1172-1182
pubmed: 29295846
Infect Immun. 2021 Apr 16;89(5):
pubmed: 33649050
Cell Rep. 2017 Aug 1;20(5):1073-1087
pubmed: 28768193
Nat Protoc. 2020 Sep;15(9):2920-2955
pubmed: 32788719
Nat Med. 2022 May;28(5):1063-1071
pubmed: 35189624
MAbs. 2018 Oct;10(7):1111-1130
pubmed: 30130439
Immunity. 2020 Oct 13;53(4):852-863.e7
pubmed: 32976769
PLoS Med. 2021 Dec 20;18(12):e1003872
pubmed: 34928960
J Transl Autoimmun. 2021 Mar 01;4:100093
pubmed: 33748735
Blood. 2003 Aug 1;102(3):887-95
pubmed: 12676790
Science. 2018 Dec 14;362(6420):1306-1309
pubmed: 30545888
Blood Adv. 2020 Sep 8;4(17):4136-4146
pubmed: 32886753
PLoS Biol. 2016 Jan 06;14(1):e1002344
pubmed: 26736041
Science. 2014 Mar 14;343(6176):1260-3
pubmed: 24626930
Nat Rev Immunol. 2002 Sep;2(9):706-13
pubmed: 12209139
J Allergy Clin Immunol. 2020 Sep;146(3):492-500
pubmed: 32721416
Nature. 2013 Apr 25;496(7446):504-7
pubmed: 23563266
Oncoimmunology. 2017 Oct 20;7(1):e1375641
pubmed: 29296532
PLoS One. 2017 Aug 17;12(8):e0182695
pubmed: 28817705
Nat Med. 2015 Aug;21(8):938-945
pubmed: 26193342
Sci Immunol. 2021 Feb 23;6(56):
pubmed: 33622975
Nat Rev Rheumatol. 2017 Sep;13(9):538-547
pubmed: 28794515
Cell. 2020 Oct 1;183(1):143-157.e13
pubmed: 32877699
N Engl J Med. 2021 Aug 26;385(9):803-814
pubmed: 34379916
Sci Transl Med. 2017 Nov 1;9(414):
pubmed: 29093180
Clin Immunol. 2016 Aug;169:128-138
pubmed: 27373969
Immunity. 2021 Dec 14;54(12):2893-2907.e5
pubmed: 34614412
J Clin Invest. 2014 May;124(5):2246-59
pubmed: 24667641
Nature. 2020 Jul;583(7817):590-595
pubmed: 32669714
N Engl J Med. 2022 Mar 17;386(11):1088-1091
pubmed: 35081298
Commun Biol. 2022 May 26;5(1):503
pubmed: 35618814
Science. 2022 May 13;376(6594):eabl4896
pubmed: 35549404
Front Immunol. 2021 Feb 12;11:594813
pubmed: 33643283
Blood Adv. 2022 Jun 28;6(12):3678-3683
pubmed: 35443020
Antibodies (Basel). 2020 Oct 13;9(4):
pubmed: 33066119
Cell. 2016 Jul 28;166(3):582-595
pubmed: 27426947
Science. 2021 Jun 4;372(6546):1102-1105
pubmed: 34083490
N Engl J Med. 2021 Jun 10;384(23):2259-2261
pubmed: 33822494
Nat Immunol. 2021 Dec;22(12):1503-1514
pubmed: 34716452
Nature. 2021 Mar;591(7851):639-644
pubmed: 33461210
Cell Rep. 2022 Mar 22;38(12):110561
pubmed: 35303475
Science. 2021 Oct 22;374(6566):472-478
pubmed: 34554826
MAbs. 2021 Jan-Dec;13(1):1873478
pubmed: 33448242
Mol Cancer Ther. 2020 Oct;19(10):2126-2138
pubmed: 32847982
Oncoimmunology. 2017 Feb 6;6(3):e1284723
pubmed: 28405516
Structure. 2019 Jan 2;27(1):196-206.e6
pubmed: 30471922
N Engl J Med. 2021 Nov 4;385(19):1774-1785
pubmed: 34551225
Int J Mol Sci. 2019 Sep 12;20(18):
pubmed: 31547243
Blood Cancer J. 2020 Apr 28;10(3):30
pubmed: 32341336
Cell. 2021 Mar 4;184(5):1201-1213.e14
pubmed: 33571429
Sci Transl Med. 2020 Jun 24;12(549):
pubmed: 32581132
Hemasphere. 2020 Dec 09;5(1):e504
pubmed: 33324950
Immunity. 2018 May 15;48(5):855-871
pubmed: 29768174
Sci Transl Med. 2017 Aug 30;9(405):
pubmed: 28855396
Cancer Immunol Res. 2018 Jan;6(1):14-24
pubmed: 29097422
Cell. 2015 Apr 23;161(3):470-485
pubmed: 25865483
MAbs. 2021 Jan-Dec;13(1):1869406
pubmed: 33427589
N Engl J Med. 2021 Dec 23;385(26):2485-2487
pubmed: 34731553
Sci Transl Med. 2020 Jan 8;12(525):
pubmed: 31915305
Nat Commun. 2021 Jul 21;12(1):4445
pubmed: 34290245
Nature. 2018 Oct;562(7727):367-372
pubmed: 30283141
Sci Adv. 2018 Oct 10;4(10):eaau1199
pubmed: 30324136
J Immunol. 2022 Nov 9;210(1):50-60
pubmed: 36351696
Nat Med. 2018 May;24(4):408-416
pubmed: 29554083
PLoS Comput Biol. 2021 Dec 13;17(12):e1009675
pubmed: 34898603
Immunity. 2021 Dec 14;54(12):2859-2876.e7
pubmed: 34788599
Mayo Clin Proc. 2022 Jan;97(1):186-189
pubmed: 34996552
J Exp Med. 2017 May 1;214(5):1547-1555
pubmed: 28420733
Cancer Immunol Res. 2020 Jun;8(6):781-793
pubmed: 32273279
Blood. 2008 Oct 1;112(7):2657-66
pubmed: 18606876